CEO, Endocells (FR)
Dr Weitsch studied for her PhD in neurobiochemistry at Cambridge University, UK and after
completing a number of years of fundamental research in the CNS area, she joined the
She spent many years in various executive R&D positions within Ciba (Novartis) followed by
worldwide executive business development responsibilities within Johnson & Johnson.
Eight years ago she decided to join the Biotechnology Industry to support SMEs in their
Business Development activities, financial engagements and Intellectual Property strategies.
As a vehicle to support these new biotechnology activities, she created ASIBELS SARL, a
Healthcare and Biotechnology consulting company, based in Switzerland with broad
Innovation in a Biotechnology Company ( 133KB)
- What does Innovation means for a young Biotechnology Company?
- How do we secure Innovation?
- How do we commercialize Innovation?